4th Jul 2018 12:05
LONDON (Alliance News) - Realm Therapeutics PLC said Wednesday it secured approval from Nasdaq for the listing of its American depositary shares on Thursday.
The company's ordinary shares will continue to be admitted to trading on London's AIM market.
"The registration statement was filed to facilitate the creation of a trading market in the US," the company said.
Realm Therapeutics shares were untraded at 38.50 pence each on Wednesday.
Related Shares:
RLM.L